Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights
Titel:
Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights
Auteur:
Elsebaie, Heba A. El-Bastawissy, Eman A. Elberembally, Kamel M. Khaleel, Eman F. Badi, Rehab Mustafa Shaldam, Moataz A. Eldehna, Wagdy M. Tawfik, Haytham O. El-Moselhy, Tarek F.